Viewing Study NCT06004128


Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-01-01 @ 2:21 AM
Study NCT ID: NCT06004128
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-06-03
First Post: 2023-08-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments
Sponsor: Invivyd, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module